This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Samanic, C. Articles by Silverman, D. T. Search for Related Content PubMed PubMed Citation Articles by Samanic, C. Articles by Silverman, D. T.

Smoking and Bladder Cancer in Spain: Effects of Tobacco Type, Timing, Environmental Tobacco Smoke, and Gender

¹ Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland; ² Institut Municipal d'Investigació Mèdica; ³ Universitat Pompeu Fabra; ⁴ Department of Pathology, Hospital del Mar-IMAS-IMIM, Universitat Pompeu Fabra, Barcelona, Spain; ⁵ Corporació Parc Taulí, Sabadell, Spain; ⁶ Department of Health, Sabadell, Spain; ⁷ Hospital General de Elche, Elche, Spain; ⁸ Unidad de Investigación, Hospital Unversitaro de Canarias, La Laguna, Spain; and ⁹ Universidad de Oviedo, Oviedo, Spain

Requests for reprints: Claudine Samanic, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, 6120 Executive Boulevard, Room 8115, Bethesda, MD 20892. Phone: 301-402-7824; Fax: 301-402-1819. E-mail: samanicc{at}mail.nih.gov

We examined the effects of dose, type of tobacco, cessation, inhalation, and environmental tobacco smoke exposure on bladder cancer risk among 1,219 patients with newly diagnosed bladder cancer and 1,271 controls recruited from 18 hospitals in Spain. We used unconditional logistic regression to estimate odds ratios (OR) and 95% confidence intervals (95% CI) for the association between bladder cancer risk and various characteristics of cigarette smoking. Current smokers (men: OR, 7.4; 95% CI, 5.3-10.4; women: OR, 5.1; 95% CI, 1.6-16.4) and former smokers (men: OR, 3.8; 95% CI, 2.8-5.3; women: OR, 1.8; 95% CI, 0.5-7.2) had significantly increased risks of bladder cancer compared with nonsmokers. We observed a significant positive trend in risk with increasing duration and amount smoked. After adjustment for duration, risk was only 40% higher in smokers of black tobacco than that in smokers of blond tobacco (OR, 1.4; 95% CI, 0.98-2.0). Compared with risk in current smokers, a significant inverse trend in risk with increasing time since quitting smoking blond tobacco was observed (20 years cessation: OR, 0.2; 95% CI, 0.1-0.9). No trend in risk with cessation of smoking black tobacco was apparent. Compared with men who inhaled into the mouth, risk increased for men who inhaled into the throat (OR, 1.7; 95% CI, 1.1-2.6) and chest (OR, 1.5; 95% CI, 1.1-2.1). Cumulative occupational exposure to environmental tobacco smoke seemed to confer increased risk among female nonsmokers but not among male nonsmokers. After eliminating the effect of cigarette smoking on bladder cancer risk in our study population, the male-to-female incidence ratio decreased from 8.2 to 1.7, suggesting that nearly the entire male excess of bladder cancer observed in Spain is explained by cigarette smoking rather than occupational/environmental exposures to other bladder carcinogens. (Cancer Epidemiol Biomarkers Prev 2006;15(7):1348–54)

This article has been cited by other articles:

				C Serra, M Kogevinas, D T Silverman, D Turuguet, A Tardon, R Garcia-Closas, A Carrato, G Castano-Vinyals, F Fernandez, P Stewart, et al. Work in the textile industry in Spain and bladder cancer Occup. Environ. Med., August 1, 2008; 65(8): 552 - 559. [Abstract] [Full Text] [PDF]

				C M Samanic, M Kogevinas, D T Silverman, A Tardon, C Serra, N Malats, F X Real, A Carrato, R Garcia-Closas, M Sala, et al. Occupation and bladder cancer in a hospital-based case-control study in Spain Occup. Environ. Med., May 1, 2008; 65(5): 347 - 353. [Abstract] [Full Text] [PDF]

				J. H. Lubin, M. C. R. Alavanja, N. Caporaso, L. M. Brown, R. C. Brownson, R. W. Field, M. Garcia-Closas, P. Hartge, M. Hauptmann, R. B. Hayes, et al. Cigarette Smoking and Cancer Risk: Modeling Total Exposure and Intensity Am. J. Epidemiol., August 15, 2007; 166(4): 479 - 489. [Abstract] [Full Text] [PDF]

				C. Murta-Nascimento, D. T. Silverman, M. Kogevinas, M. Garcia-Closas, N. Rothman, A. Tardon, R. Garcia-Closas, C. Serra, A. Carrato, C. Villanueva, et al. Risk of Bladder Cancer Associated with Family History of Cancer: Do Low-Penetrance Polymorphisms Account for the Increase in Risk? Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1595 - 1600. [Abstract] [Full Text] [PDF]

				X. Jiang, J.-M. Yuan, P. L. Skipper, S. R. Tannenbaum, and M. C. Yu Environmental Tobacco Smoke and Bladder Cancer Risk in Never Smokers of Los Angeles County Cancer Res., August 1, 2007; 67(15): 7540 - 7545. [Abstract] [Full Text] [PDF]

				J. H Lubin, M. Kogevinas, D. Silverman, N. Malats, M. Garcia-Closas, A. Tardon, D. W Hein, R. Garcia-Closas, C. Serra, M. Dosemeci, et al. Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish Bladder Cancer Study Int. J. Epidemiol., February 1, 2007; 36(1): 236 - 241. [Abstract] [Full Text] [PDF]

				Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1568 - 1568. [Full Text] [PDF]